Last update 21 Nov 2024
REGEND-001
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Cell therapy |
Synonyms |
Target- |
Mechanism Cell replacements |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
6
Clinical Trials associated with REGEND-001A Multi-center, Randomized, Double-Blinded, Parallel and Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy in Idiopathic Pulmonary Fibrosis (IPF) Patients
一项评价REGEND001 细胞自体回输制剂移植治疗特发性肺纤维化患者有效性、安全性的多中心、随机、双盲、安慰剂平行对照II 期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled Phase II clinical study to evaluate the efficacy and safety of autologous retransfusion of REGEND001 cells in the treatment of patients with idiopathic pulmonary fibrosis
REGEND001细胞自体回输制剂移植治疗肺弥散功能障碍的慢性阻塞性肺疾病（COPD）的
探索性临床研究（多中心、随机、单盲、安慰剂平行对照）
[Translation] An exploratory clinical study of autologous retransfusion of REGEND001 cells for the treatment of chronic obstructive pulmonary disease (COPD) with pulmonary diffusion dysfunction (multicenter, randomized, single-blind, placebo-controlled)
100 Clinical Results associated with REGEND-001
Login to view more data
100 Translational Medicine associated with REGEND-001
Login to view more data
100 Patents (Medical) associated with REGEND-001
Login to view more data
100 Deals associated with REGEND-001
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | Phase 2 | CN | 30 Jun 2023 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | CN | 20 Jun 2022 | |
| Thyroid Hormone Plasma Membrane Transport Defect | Phase 2 | CN | 20 Jun 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free